Identification of a Homozygous PGM2L1 Variant in a Male Patient With Developmental Delay and Seizures
Molecular Genetics & Genomic Medicine · 2026-03 · 14 (3)
DOI: 10.1002/mgg3.70195 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 03.03.2026. Verfasst von Mengmeng Niu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xi'an Children's Hospital, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Developmental Disabilities, Seizures. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shaanxi Provincial Key Research and Development Program.
Abstract (Originalsprache)
Background
PGM2L1 gene variants are associated with developmental delays, seizures, and various neurological and physical symptoms. This study aims to report the clinical features and genetic findings in a male patient with developmental delay, regression, and seizures.
Methods
Whole‐exome sequencing (WES) was performed on the patient to identify the genetic etiology of the patient. Sanger sequencing was used for variant confirmation. Clinical evaluations were conducted, including cerebrospinal fluid analysis, cranial MRI, EEG, and neurological assessments.
Results
The patient is a 1‐year‐old male who presented with psychomotor delays and developed seizures and impaired consciousness at 1 year of age. Cranial MRI revealed bilateral frontotemporal subarachnoid widening. Developmental regression was observed shortly after the onset of seizures. The EEG results showed diffuse slow background activity and epileptiform discharges. WES identified a rare homozygous variant in the PGM2L1 gene (OMIM: 611,610, NM_173582.6: c.1673delC, p.Thr558Ilefs*19), which was inherited from both parents. Sanger sequencing confirmed the presence of the variant, and it was evaluated as a likely pathogenic variant according to American College of Medical Genetics and Genomics (ACMG) guidelines.
Conclusion
Our study was the second report of a PGM2L1 gene variant associated with early‐onset developmental delay and seizures, further expanding the genetic spectrum of this disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Xi'an Children's Hospital, Xi'an, Shaanxi, China.
- Department of Neurology, Xi'an People's Hospital, Xi'an, Shaanxi, China.
ORCID-Profile: Shanshan Jia
Förderung
- Shaanxi Provincial Key Research and Development Program
Zitieren
APA
Niu, M., Wang, D., & Jia, S. (2026). Identification of a Homozygous PGM2L1 Variant in a Male Patient With Developmental Delay and Seizures. Molecular Genetics & Genomic Medicine, 14(3). https://doi.org/10.1002/mgg3.70195
Vancouver
Niu M, Wang D, Jia S. Identification of a Homozygous PGM2L1 Variant in a Male Patient With Developmental Delay and Seizures. Molecular Genetics & Genomic Medicine. 2026;14(3). doi:10.1002/mgg3.70195
BibTeX
@article{Niu2026,
author = {Niu, Mengmeng and Wang, Dong and Jia, Shanshan},
title = {Identification of a Homozygous PGM2L1 Variant in a Male Patient With Developmental Delay and Seizures},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/mgg3.70195}
}
EUVIMED